Its going to be, itll come in stages but itll be from 1 to 3 years
CrossRef Cyanidin-3-O-glucoside enhances GLP-1 secretion via PPAR/--catenin-TCF-4 pathway in type 2 diabetes mellitus Xiang Ye, Wen Chen, Fujie Yan, Xiaodong Zheng, Pengcheng Tu npj Science of Food.2025;[Epub] CrossRef Local Insulin for Local Needs
A post hoc analysis of the REMODEL trial, presented by David Cherney, MD, PhD, and colleagues at the International Society of Nephrology World Congress of Nephrology in Yokohama, Japan, assessed the kidney-protective effects of semaglutide 1.0 mg among adults with type 2 diabetes (n=71), stratified by SGLT2 inhibitor use
Market context: where Cora and Ro Body sit in the 2026 GLP-1 telehealth market Four numbers anchor the head-to-head comparison between Cora Health and Ro Body in 2026: 41.9% US adult obesity prevalence